Sarah Clements
General Counsel at INTERNATIONAL CONSOLIDATED AIRLINES GROUP, S.A.
Profile
Sarah Clements is currently the General Counsel at International Consolidated Airlines Group SA and a Trustee at Solent Mind.
She previously worked as the Senior Vice President at GSK Plc and as the Vice President-Legal & International at Alexion Pharmaceuticals, Inc. Ms. Clements completed her undergraduate degree at Newcastle University.
Sarah Clements active positions
| Companies | Position | Start |
|---|---|---|
| INTERNATIONAL CONSOLIDATED AIRLINES GROUP, S.A. | General Counsel | 2022-10-31 |
Solent Mind
 Solent Mind Miscellaneous Commercial ServicesCommercial Services Solent Mind is a mental health charity based in Hampshire, UK. The British company provides emotional wellbeing and mental health support for people living in the area. The non-profit company aims to fight against stigma and inspire others to care for their mental health. Sally Arscott has been the CEO of the company since 2022. | Director/Board Member | - |
Former positions of Sarah Clements
| Companies | Position | End |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 2022-10-31 |
| ALEXION PHARMACEUTICALS, INC. | General Counsel | - |
Training of Sarah Clements
| Newcastle University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| INTERNATIONAL CONSOLIDATED AIRLINES GROUP, S.A. | Transportation |
| GSK PLC | Health Technology |
| Private companies | 2 |
|---|---|
Solent Mind
Solent Mind Miscellaneous Commercial ServicesCommercial Services Solent Mind is a mental health charity based in Hampshire, UK. The British company provides emotional wellbeing and mental health support for people living in the area. The non-profit company aims to fight against stigma and inspire others to care for their mental health. Sally Arscott has been the CEO of the company since 2022. | Commercial Services |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Sarah Clements
